Evidence-based national vaccine policy

Indian Journal of Medical Research

Volumn 131, Issue 5, 2010, Pages 617-628

  Madhavi, Y ^a   Puliyel, Jacob M ^b   Mathew, Joseph L ^c   Raghuram, N ^d   Phadke, Anant ^e   Shiva, Mira ^f   Srinivasan, S ^g   Paul, Yash ^h   Srivastava, R N ⁱ   Parthasarathy, A ^j   Gupta, Sunil ^k   Ranga, Udaykumar ^l   Lakshmi, V Vijaya ^m   Joshi, Nayana ⁿ   Nath, Indira ^o   Gulhati, C M ^p   Chatterjee, Prabir ^q   Jain, Anuradha ^r   Priya, Ritu ^s   Dasgupta, Rajib ^s   Sridhar, S ^q   Dabade, Gopal ^t   Gopakumar, K M ^u   Abrol, Dinesh ^a   Santhosh, M R ^v   Srvastava, Sadhana ^w   Visalakshi, S ^a   Bhargava, Anurag ^x   Sarojini, N B ^y   Sehgal, Devinder ^z   Selvaraj, Sakthivel ^aa   Banerji, D ^s   more..

^a National Institute of Science Technology and Development Studies India   (India)

^b ST STEPHEN S HOSPITAL   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^e SATHI   (India)

^f All India Drug Action Network (AIDAN) and Initiative for Health Equity and Society   (India)

^g Low Cost Standard Therapeutics   (India)

^h Maharaja Agrasen Hospital   (India)

ⁱ INDRAPRASTHA APOLLO HOSPITAL   (India)

^j INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN   (India)

^k National Centre for Disease Control   (India)

^l JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^m LEPRA Society   (India)

ⁿ NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^o SAFDARJUNG HOSPITAL CAMPUS   (India)

^p AE Morgan Publications (India) Private Limited   (India)

^q Medico Friends Circle ^*  (India)

^r NATIONAL INSTITUTE OF HEALTH AND FAMILY WELFARE   (India)

^s JAWAHARLAL NEHRU UNIVERSITY   (India)

^t AIDAN and Drug Action Forum Karnataka (DAF K)   (India)

^u Third World Network   (India)

^v Centre for Trade and Development   (India)

^w INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^x Jan Swasthya Sahyog   (India)

^y Sama Resource Group for Women and Health   (India)

^z NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^aa PUBLIC HEALTH FOUNDATION OF INDIA   (India)

more..

Author keywords

Combination; Cost benefit; Epidemiology; Immunization; Policy; Private; Public; Public health; UIP; Vaccine

Indexed keywords

BCG VACCINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TYPHOID VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ARTICLE; BRAINSTORMING; BUDGET; CONSENSUS DEVELOPMENT; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDIA; MASS IMMUNIZATION; PRACTICE GUIDELINE; PUBLIC HEALTH; RESOURCE ALLOCATION; VACCINATION; VACCINE PRODUCTION;

BUDGETS; DECISION SUPPORT SYSTEMS, CLINICAL; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNIZATION PROGRAMS; INDIA; VACCINES;

EID: 77952362162     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Madhavi Y. Transnational factors and national linkages: Indian experience in Human Vaccines. Asian Biotech Dev Rev 2007; 9: 1-43.
2. Department of Biotechnology Annual Report 1986-87. New Delhi: Department of Biotechnology, Ministry of Science and Technology, Government of India; 1987.
3. Madhavi Y. Meeting local needs in global time; the case of universal vaccines in India. J Health Studies 2009; 2: 81-105.
4. Madhavi Y. Vaccine policy in India. PLoS Med 2005; 2: e127: 0387-91.
5. Madhavi Y. New combination vaccines: Backdoor entry into India's Universal Immunization Programme? Cur Sci 2006; 90: 1465-9.
6. Sokhey J, Kim-Farley RJ, Bhargava I. Expanded programme on immunization: a decade of progress in India. Ann Trop Pediatr 1989; 9: 24-9.
7. Patra N. Exploring the determinants of childhood immunization. Econ Polit Wkly 2008; 43: 97-104.
8. Ramachandran R. Vaccine fiasco. Frontline 2009;26(7). Available from: http://www.hinduonnet.com/fline/fl2607/stories/20090410260711400.htm, accessed on April 10, 2010.
9. Cormac S. The business of making vaccines. Nature 2005; 23: 1359-66.
10. Almeida M, Shenoy M. War of the doses. Business India 1997; Sept. 8-21: 142, 144.
11. Madhavi Y. The manufacture of consent? Hepatitis B vaccination, A special article. Econ Polit Wkly (EPW) 2003; 38: 2417-24.
12. Patel V, Vaidya R, Naik D, Borker P. Irrational drug use in India: A prescription survey from Goa. J Postgrad Med 2005; 51: 9-12.
13. 34th Parliamentary Standing Committee on Health and Family Welfare, Parliament of India, Rajya Sabha, Government of India, New Delhi; 2009.
14. Sinha K. Coming soon: Five-in-one vaccination shot for kids. Times of India 2009; 15th July. Available from: http://timesofindia.indiatimes.com/NEWS/India/Coming-soon-Five-in-one-vaccination-shot-for-kids/articleshow/4777339.cms accessed on April 10, 2010.
15. Kalra A. Polio eradication and environment. Indian Pediatr 2008; 45: 388-90.
16. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
17. Aneja H, Puliyel JM. Selling vaccines: Deciding on who can afford HPV. Indian Pediatr 2009; 46: 647.
18. Narula D, Tiwari L, Puliyel JM. Rotavirus vaccines. Lancet 2004; 364: 245-6.
19. Mathew J. Pneumococcal vaccination in developing countries: Where does science end and commerce begin? Vaccine 2009; 27: 4247-51.
20. Endean C. Pneumococcal vaccine's average cost is $4.25. The Hindu, Chennai, Monday, Jul 06, 2009. Available from: http://www.thehindu.com/2009/07/06/stories/2009070660291200.htm, accessed on April 10, 2010.
21. Gupta N, Puliyel JM. Vaccine introduction where incidence of Hib meningitis is 0.007%: Decision-making based on health economic or ideology? Indian J Med Res 2009; 129: 339-40.
22. Disease burden in India, Estimation and causal analysis. NCMH Background paper, 1-6. Available from: (http://www.whoindia.org/LinkFiles/Commision_on_Macroeconomic_and_Health_Bg_P2_Burden_of_Disease_Estimations_and_Casual_analysis.pdf), accessed on April 10, 2010.
23. Narain JP, Banerjee KB. Measles in India: Epidemiology and control. Indian Pediatr 1989; 56: 463-72.
24. Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingrai N, et al. RGI-CGHR Prospective Study Collaborators. Prospective study of one million deaths in India: Rationale, design, and validation results. Plos Med 2006; 3(2) e18: 0191-0200.
25. Phadke A, Kale A. Some critical issues in the epidemiology of hepatitis-B in India. Indian J Gastroenterol 2000; 19 (Suppl 3): C76-C7.
26. Lodha R, Jain Y, Anand K, Kabra SK, Pandav CS. Hepatitis B in India. A review of disease epidemiology. Indian Pediatr 2001; 38: 349-71.
27. Puliyel JM, Madhavi Y. Vaccines: Policy for public good or private profit? Indian J Med Res 2008; 127: 1-3.
28. Arora R, Puliyel JM. Economic evaluation tailored to promote vaccine uptake: how third world consumers can respond. Expert Rev Pharmacoeconomics Outcomes Res 2005; 5: 515-6.
29. Mathew JL, Singh M. Evidence based child health: Fly but with feet on the ground! Indian Pediatr 2008; 45: 95-8.
30. Mehta N. India key market for vaccine makers. The Economic Times, 26 March, 2009. Available from: http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/India-key-market-for-vaccine-makers/articleshow/4316693.cms, accessed on April 10, 2010.
31. Anuradha B, Shilpa SR, Ishaq M, Murthy KJR, Valluri VL. Interferon-? low producer genotype +874 overrepresented in BCG nonresponding children. Pediatr Infect Dis J 2008; 27: 325-9.
32. Joshi N, Yr NK, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus Hyderabad, India. Trop Gastroenterol 2000; 21: 63-5.
33. Joshi N, Roa S, Kumar A, Patil S, Rani S. Hepatitis A vaccination in chronic liver disease: Is it really required in a tropical country like India? Indian J Med Microbiol 2007; 25: 137-9.
34. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJF, Vaccarella S, et al; and the IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8.
35. Madhavi Y. Human vaccine science and technology status in India. In: Banerjee P, editor. India science & technology 2008. New Delhi: NISTADS CSIR; 2009.
36. Sokhey J, Jain DC, Harit AK, Dhariwal AC. Moderate immunization coverage levels in east Delhi: Implications for disease control programmes and introduction of new vaccines. J Trop Pediatr 2001: 47: 199-203.
37. Datar A, Mukherji A, Sood N. Health infrastructure & immunization coverage in rural India. Indian J Med Res 2007; 125: 31-42.
38. Balraj V, Mukundan S, Samuel R, John TJ. Factors affeting immunization coverage levels in a district of India. Int J Epidemiol 1993; 22: 1146-53.
39. Sharma S. Immunization coverage in India. Delhi: Working Paper Series No. E/283/2007; 1-29. Delhi: University of Delhi; 2007.
40. Agarwal S, Bhanot A, Goindi G. Understanding and addressing childhood immunization coverage in urban slums. Indian Pediatr 2005; 42: 653-63.
41. Singh A. Record-based immunization coverage assessment in rural north India. Internet J Third World Med 2007; 4. Available from: http://www.ispub.com/journal/the_internet_journal of third_world_medicine/volume_4_number_1_53/article/record_based_immunization coverage_assessment_in_ruralnorth_india.html, accessed on April 10, 2010.
42. Punith K, Lalitha K, Suman G, Pradeep BS, Kumar KJ. Evaluation of primary immunization coverage of infants under universal immunization programme in an urban area of Bangalore city using cluster sampling and lot quality assurance sampling techniques. Indian J Commun Med 2008; 33: 151-5.
43. Dav, Veena, Das DK, Coutinho L. Disease control and immunisation: A social enquiry. Econ Polit Wkly 2000; 2: 625-32.
44. Rachna Programme 2001-2006. Women and child health at scale, Working papr series (7), Widening coverage of primary immunization. New Delhi: Rachna & CARE India; 2007 p. 1-33.
45. Wyatt HV. Polio eradication in India: some queries. Natl Med J India 2003; 16: 340-2.
46. John TJ. Problems with oral polio vaccine in India. Indian Pediatr 1972; 9: 252-6.
47. Kohler KA, Banerjee K, Hlady WG, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull World Health Organ 2002; 80: 210-6.
48. Sathyamala C, Mittal O, Dasgupta R, Ritu Priya. Polio eradication initiative in India: Deconstructing the GPEI. Int J Health Services 2005; 35: 361-83.
49. Puliyel JM, Sathyamala C, Banerji D. Protective efficacy of a monovalent oral type 1 poliovirus vaccine. Lancet 2007; 370: 129.
50. Bulletin of Polio Eradication Committee. Indian Academy of Pediatrics (IAP). Indian Acad Pediatr 2005; 2: 1-15.
51. Mittal SK, Mathew JL. Polio eradication in India: the way forward. Indian J Pediatr 2007; 74: 153-60.
52. Paul Y. Why has polio eradication program failed in India? Indian J Pediatr 2008; 45: 381-8.
53. Dasgupta R, Chaturvedi S, Adish SV, Ganguly KK, Rai S, Sushant L, et al. Social determinants and polio 'endgame': A qualitative study in high risk district of India. Indian J Pediatr 2008; 45: 357-66.
54. Ghosh A. Eighth Plan: Challenges and opportunities-XII, Health, maternity and child care: Key to restraining population growth. Econ Polit Wkly 1991; 20: 1017-22.
55. Robbins A. Modern vaccines. Progress towards vaccines we need and do not have. Lancet 1990; 335: 1436-8.
56. The Task Force for Child Survival, Protecting the World's Children. Bellagio II, Colombia, Oct 1985. New York: Rockefeller Foundation; 1986.
57. National Planning Committee. Report of the Sub-Committee on National Health. Bombay: Vora & Co; 1948. p. 224-5.
58. Sela M, Maurice RH. Therapeutic vaccines: Realities of today and hopes for tomorrow. Proc Natl Acad Sci USA 2004; 101: 14559.
59. Dan J. Rethinking on therapeutic cancer vaccines, news feature and analysis. Nature Rev Drug Discovery 2009; 8: 685-6.
60. National mission on immunization. New Delhi: Ministry of Health and Family Welfare, Government of India; 1988.
61. Towards universal immunization by 1990. New Delhi: Ministry of Health and Family Welfare, Government of India; 1985.
62. Balestra D, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? J Gen Intern Med 1993; 8: 405-12.
63. Anuradha B, Santosh CM, Hari Sai PV, Suman LG, Murthy KJR, Valluri VL. Age -related waning of in vitro Interferon-? levels against r32k Da BCG in BCG vaccinated children. J Immun Based TherapVaccines 2007; 5: 8.
64. Taneja DK. Newer vaccines-need for informed choice. Available from: http://delhimedicalcouncil.nic.in/newervaccines.htm, accessed on April 11, 2010
65. Mathew JL. HPV vaccine in the Indian context. Indian J Pediatr 2009; 46: 645.
66. Kaplan M. Do flu vaccines work for the elderly? Nature News 2007; Published online 25 September 2007. Available from: http:www.nature.com/news/2007/070925/full/news070924-3.html, accessed on April 10, 2010.
67. Violation of DCGI directive causefrom shortage of antirabies vaccine. Express News Service July 21, 2008. Available from: http://www.expressindia.com/latest-news/Violation-of-DCGI-directive-cause-for-shortage-of-anti-rabies-vaccine/338245/. accessed on April 10, 2010.
68. Ubol S, Phanuphak P. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. Clin Exp Immunol 1986; 63: 491-7.
69. Kale A, Phadke A. The case for intradermal route Hepatitis B vaccination. A pre-publication draft CEHAT 2000: Cehat Pune. Available from: http://www.cehat.org/publications/pa31a74.html, accessed on September 23, 2009.
70. Playford EG, Hogan PG, Bansal AS, Drummond D, Whitby M. Vaccination with intradermal recombinant hepatitis B vaccine in healthcare workers who fail to respond to intramuscular vaccination. Interscience Conference on Antimicrobial Agents and Chemotherapy, Princess Alexandra Hosp., Brisbane, AUSTRALIA Sep 26-29, 1999; 39: 373 (abstract no.678).
71. Madhavi Y. Home grown vaccines are crucial for public health. Opinions, Scidev.net 23; September 2009. Available from: http://www.scidev.net/en/opinions/home-grown-vaccines-are-crucial-for-public-health.html, accessed on April 10
72. Kounteya Sinha. 49 babies die during clinical trials at AIIMS, Times of India 18 August 2008. Available from: http://www.timesofindia.com/articleshow/msid3374492,prtpage-1.cms, accessed on April 10, 2010.
73. Debarshi D. Immuity to reason, India plans to adopt a pneumonia vaccine that doesnt work and has ill side-effects. Outlook 8th Sept, 2008. Available from: http://www.outlookindia.com/article.aspx?238352, accessed on April 10, 2010.
74. Gulathi CM. Needed: Closer scrutiny of clinical trials. Indian J Med Ethics 2008; 12(1). Available from: http://www.issuesinmedicalethics.org/121ed004.html, accessed on April 10, 2010.
75. Sahay S, Mehendale S. Addressing ethical concerns in the Indian HIV vaccine trials. Indian J Med Ethics 2004; 1: 109.
76. Srivastava M. Pulse polio bungle: Untested vaccine surfaces in polio outbreak. Tehelka July 28,2007. Available from: http://www.tehlka.com/story_main33.asp=Ne280707untestedvaccineasp.accessed on April 10, 2010.
77. Rafiq MMD, Sufoora BMD, Masoodi MAMD. Coverage evaluation survey of immunization programme in hilly and plain area of field practice area of government medical college, Srinagar. JK Pract 2004; 11: 149-59.
78. Drug Policy Economy Watch. Available from: http://www.economywatch.com/policywatch/drugpolicy.html, accessed on April 10, 2010.
79. Drugs Under Price Control: Why it needs to be revised in 2004 in the light of the public health crisis in India. Extracts from the written submission on behalf of mfc LOCOST, JSS and AIDAN to the committee on pricing set up by the Government of India under the Chairmanship of Shri G.S. Sandhu, Ministry of Chemicals and Fertilisers, New Delhi, November 2004. Available from: http://www.mfcindia.org/DUPC.pdf, accessed on April 10, 2010.
80. Thawani V, Gharpure K. Monitoring misuse of the WHO name and emblem in medicine promotion in India. Indian J Med Ethics 2009; 6: 10-4.
81. Vijaya VL, Shilpa SR, Anu Radha BV, Hari SP, Vinod P, Sushmita J, et al. Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis. Infect Gen Evol 2006; 6: 436-43.
82. Chaudhuri Keya, Chatterjee SN. Cholera toxin (CT): Immune response of the host and vaccine production. In: Chaudhuri Keya, Chatterjee SN, editors. Cholera toxins. Springer; Berlin: Heidlberg Publishers; 2009. p. 199-212.
83. Surekha RH, Valluri VL, Sumanlatha G, Murthy KVR. Cell-mediated immune responses in children towards secreted proteins of Mycobacterium bovis BCG. Tuberculosis 2005; 85: 89-93.
84. Madhavi Y. Liberalization and the cost-benefit aspects of vaccines: the case of hepatitis B. Working paper series 1, CHS/WP/01/01, 2001. Mumbai: Centre for Health Studies, Tata Institute of Social Sciences; 2001.
85. 100-day agenda: Azad reverses Anbumani's decision, Govt to reopen vaccine units. Deccan Herald July 6th 2009; New Delhi.
86. Mathew A. DPT-Hib combination: Logical fallacy and circular argument. Indian J Pediatr 2006; 43: 508-10.
87. Mathew JL. Influenza vaccination for children in India. Indian pediatr 2009; 46: 304-7.
88. Puliyel JM, Agarwal KS, Abed Abass FA. Natural immunity to haemophilus influenza b in infancy in Indian children. Vaccine 2001;19: 4592-4.
89. Ramachandran R. Vaccine worries.Frontline 2008; 25:4-27. Available from: http://hindu.com/fline/fl2507/stories/20080411250700400.htpp. accessed on April 10, 2010.